A population-based case-control teratologic study of nalidixic acid

International Journal of Gynecology and Obstetrics

Volumn 73, Issue 3, 2001, Pages 221-228

  Czeizel, A E ^a   Sorensen H T ^b   Olsen, J ^b  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Case control analysis; Congenital abnormalities; Human teratogenic potential; Nalidixic acid; Pyloric stenosis

Indexed keywords

NALIDIXIC ACID; QUINOLONE DERIVATIVE; TERATOGENIC AGENT;

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; FEMALE; GENETIC DISORDER; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PYLORUS STENOSIS; TERATOLOGY; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME;

EID: 0035370369     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(01)00345-9     Document Type: Article

References (24)

1. Hooper D.C. Quinolones. Principles and practice of infectious diseases. Churchill Livingstone, New York. 1995;364-376.
2. Andriole V.T. The quinolones. 1988;Academic Press. London.
3. Giamarellou H., Kolokythas E., Petrikkos G., Gazis J., Aravatinos D., Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med. 87:(Suppl. 5A):1989;49S-51S.
4. Product information. NegGram. Sanofi Winthrop Pharmaceuticals, 1997.
5. Friedman J.M., Polifka J.E. The effects of drugs on the fetus and nursing infant. 1996;Johns Hopkins Univ. Press, Baltimore.
6. Czeizel A.E., Rácz J. Evaluation of drug intake during pregnancy in the Hungarian case-control surveillance of congenital anomalies. Teratology. 42:1990;505-512.
7. Czeizel A.E. The role of pharmacoepidemiology in pharmacovigilance: rational drug use in pregnancy. Pharmacoepid Drug Saf. 8:1999;S55-S61.
8. Czeizel A.E. The first 25 years of the Hungarian congenital abnormality registry. Teratology. 55:1997;299-305.
9. Stata Corp. STATA Statistical Software: Release 4.0 for Windows Stata Corporation. College Station. Texas, 1997.
10. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in pregnancy and lactation. 5th ed. Williams and Wilkins. Baltimore. 1998.
11. Asscher A.W. Diseases of the urinary system. Urinary tract infections. Br Med J 1997; (i): 1332.
12. Murray E.D.S. Nalidixic acid in pregnancy. Br Med J. 282:1981;224.
13. Pagnini G., Pelagalli G.V., Di Carlo F. Effect of nalidixic acid on the chick embryo and on pregnancy and embryonic development in rabbits and rats. Atti Soc Ital Sci Vet. 25:1971;137-140.
14. Sato T., Kobayashi F. Teratological study on cinoxacin in rabbits. Chemotherapy. 28:(Suppl. 4):1980;508-515.
15. Sato T., Kaneko Y., Saegusa T., Kobayashi F. Reproduction studies of cinoxacin in rats. Chemotherapy. 28:(Suppl. 4):1980;484-507.
16. Schaefer C., Amoura-Elefant E., Vial T., Ornoy A., Garbis H., Robert E., et al. Pregnancy outcome after prenatal quinolone exposure: evaluation of a case registry of the European Network of Teratology Information Service (ENTIS). Int J Obstet Gynecol. 69:1996;83-89.
17. Berkovits M., Pastuszak A., Gazarian M., Lewis M., Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol. 84:1994;535-538.
18. Loebstein R., Addis A., Ho E., Andreou R., Sage S., Donnenfeld A.E., et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother. 42:1998;1336-1339.
19. Källen B. Epidemiology of human reproduction. 1988;CRC Press. Boca Raton, Florida.
20. Czeizel A.E. Incidence and birth weight distribution of congenital pyloric stenosis in Budapest, Hungary. Arch Dis Child. 47:1972;978-980.
21. Carter C.O., Evans K.A. Inheritance of congenital pyloric stenosis. Med Genet. 6:1969;233-254.
22. Vanderwinden J.M., Mailleux P., Schiffmann S.N., Vanderhaeghen J.J., De Laet M.H. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med. 327:1992;511-515.
23. Chung E., Curtis D., Chen G., Marsden P.A., Twels R., Xu W., et al. Genetic evidence for the neuronal nitric oxide synthase gene (NOS1) as a susceptibility locus for infantile pyloric stenosis'. Am J Hum Genet. 58:1996;363-370.
24. Honein M.A., Paulozzi L.J., Himelright I.M., Lee B., Cragan J.D., Patterson L., et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet. 354:1999;2101-2105.